Edition:
United States

Sangamo Therapeutics Inc (SGMO.OQ)

SGMO.OQ on NASDAQ Stock Exchange Global Select Market

16.90USD
8 Dec 2017
Change (% chg)

$-0.30 (-1.74%)
Prev Close
$17.20
Open
$17.55
Day's High
$17.70
Day's Low
$16.80
Volume
242,541
Avg. Vol
347,060
52-wk High
$18.40
52-wk Low
$2.65

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Alexander Macrae

54 2016 President, Chief Executive Officer, Director

Kathy Yi

45 2017 Chief Financial Officer, Senior Vice President

Edward Conner

44 2016 Senior Vice President and Chief Medical Officer

Curt Herberts

36 2016 Senior Vice President and Chief Business Officer

Dale Ando

60 2004 Vice President - Therapeutic Development, Chief Medical Officer